Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF‐dependent manner
- 14 February 2011
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 25 (6), 1836-1843
- https://doi.org/10.1096/fj.10-172981
Abstract
Human endothelial progenitor cells (hEPCs) participate in neovascularization of ischemic tissues. Function and number of hEPCs decline in patients with cardiovascular disease, and therapeutic strategies to enhance hEPC function remain an important field of investigation. The Wnt signaling system, comprising 19 lipophilic proteins, regulates vascular patterning in the developing embryo. However, the effects of Wnts on hEPCs and the adult vasculature remain unclear. We demonstrate here that Wnt1 is expressed in a subset of endothelial cells lining the murine embryonic dorsal aorta and is reactivated in malignant angiosarcoma, suggesting a strong association of Wnt1 with angiogenesis. We investigate the effects of Wnt1 in enhancing hEPC function and blood flow to ischemic tissues and show that Wnt1 enhances the proliferative and angiogenic functions of hEPCs in a hepatocyte growth factor (HGF)-dependent manner. Injection of Wnt1-expressing hEPCs increases blood flow and capillary density in murine ischemic hindlimbs. Furthermore, injection of Wnt1 protein alone similarly increases blood flow and capillary density in ischemic hindlimbs, and this effect is associated with increased HGF expression in ischemic muscle. These findings demonstrate that Wnt1, a marker of neural crest cells and hitherto unknown angiogenic function, is a novel angiogenic protein that is expressed in developing endothelial cells, exerts salutary effects on postnatal hEPCs, and can be therapeutically deployed to increase blood flow and angiogenesis in ischemic tissues.Keywords
Funding Information
- National Institutes of Health
- Ellison Medical Foundation
This publication has 24 references indexed in Scilit:
- Hard Luck Stories: The Reality of Endothelial Progenitor Cells Continues to Fall Short of the PromiseCirculation, 2010
- Paracrine Mechanisms in Adult Stem Cell Signaling and TherapyCirculation Research, 2008
- Wnt/Frizzled signaling in angiogenesisAngiogenesis, 2008
- Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapyBritish Journal of Cancer, 2007
- Ex Vivo Gene Therapy for Hemophilia A That Enhances Safe Delivery and Sustained In Vivo Factor VIII Expression from Lentivirally Engineered Endothelial ProgenitorsThe International Journal of Cell Cloning, 2007
- Therapeutic Potential of Endothelial Progenitor Cells in Cardiovascular DiseasesHypertension, 2005
- Wnt/β-Catenin Signaling Induces Proliferation, Survival and Interleukin-8 in Human Endothelial CellsAngiogenesis, 2005
- Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repairNature, 2004
- Inhibition of Wnt-1 Signaling Induces Apoptosis in β-Catenin-Deficient Mesothelioma CellsCancer Research, 2004
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJCI Insight, 2000